WeedMD will contribute samples of 25 strains for cannabinoid composition analysis to create comprehensive profiles of each strains unique characteristics.
Guidelines warn health risks may outweigh benefits but in reality clinical evidence to support claims either way is lacking.
With a fusion of modern and classic microbiological techniques, CW Analytical now offers their California clients selective plating, biochemical profiling, protein fingerprinting, DNA-based assays, and morphological analyses.
A report from the American Osteopathic Association has aggregated medicinal cannabis research findings to help physicians give the best evidence-based recommendations and, highlights big knowledge gaps.
By taking the process online, both existing and new researchers can submit their applications through a dedicated web portal, hopefully improving efficiency and security.
“As the first Florida Cannabis Testing lab that has achieved ISO 17025 accreditation, EVIO Labs Florida continues to set the bar for testing in the state,” Christopher Martinez, EVIO Labs Florida’s President.
An early lab pilot of molecular tagging technology has demonstrated how members of the cannabis supply chain could be able to prove, with scientific certainty, that their products originate from their facilities or other legal sources.
The partnership will continue to investigate the effectiveness of cannabinoid treatment in cancer, develop novel drug delivery methods and explore the mechanisms of action of cannabinoids in disease management.
A group of emerging and established organizations within the California cannabis market have joined forces to offer education, perspective and a solution to the contaminated cannabis problem facing the State post-legalization.